TC BioPharm (Holdings) PLC (TCBP)
1.50
+0.07
(+4.90%)
USD |
NASDAQ |
May 01, 16:00
1.50
0.00 (0.00%)
After-Hours: 18:46
TC BioPharm Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2021 | -4.183M |
| Date | Value |
|---|---|
| September 30, 2020 | -2.469M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.183M
Minimum
Sep 2021
-2.469M
Maximum
Sep 2020
-3.326M
Average
-3.326M
Median
Cash from Operations (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | -14.68M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | 0.4825M |
| Autolus Therapeutics PLC | -24.83M |
| Mereo BioPharma Group PLC | -- |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -13.42M |
| Free Cash Flow Yield | -2.90K% |